<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10034">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02976324</url>
  </required_header>
  <id_info>
    <org_study_id>EDPCCP2016</org_study_id>
    <nct_id>NCT02976324</nct_id>
  </id_info>
  <brief_title>The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale</brief_title>
  <official_title>The Effect of External Diaphragmatic Pacemaker on the Patients With Chronic Cor Pulmonale</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhang Xiangyu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of external diaphragmatic pacemaker on the patients with
      chronic cor pulmonale. Half of participants will receive external diaphragmatic pacemaker,
      while the other half will receive routine therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigate the effect of external diaphragmatic pacemaker on chronic cor pulmonale, the
      indicators include: respiratory muscle force, diaphragmatic degree of excursion and
      thickness, pulmonary artery pressure, respiratory distress, feeling of fatigue and quality
      of life, pulmonary function,NT-proBNP,PaO2 and PaCO2.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiopulmonary function</measure>
    <time_frame>10 days</time_frame>
    <description>six miunte walk test</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">69</enrollment>
  <condition>Chronic Cor Pulmonale</condition>
  <arm_group>
    <arm_group_label>external diaphragmatic pacemaker group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use the external diaphragmatic pacemakerI 9 counts per minute, with stimulate frequency 40 Hz</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No inervention, just receive conventional therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>external diaphragmatic pacemaker group</intervention_name>
    <description>9 counts per minute, with stimulate frequency 40 Hz</description>
    <arm_group_label>external diaphragmatic pacemaker group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of chronic cor pulmonale and admit to hospital

        Exclusion Criteria:

          -  pneumothorax or mediastinal emphysema

          -  active tuberculosis

          -  install a cardiac pacemaker

          -  acute cardiocerebrovascular events: acute myocardial infarction, acute myocarditis,
             severe arrhythmia, severe cerebrovascular accidents.

          -  pregnancies

          -  end-stage patients (expected survival time less than 6 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiangyu zhang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xiangyu ZHANG, Doctor</last_name>
    <email>xiangyu62@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>qixing wang, Bachelor</last_name>
    <email>wangqixing1221@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Tenth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 24, 2016</lastchanged_date>
  <firstreceived_date>November 8, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tongji University</investigator_affiliation>
    <investigator_full_name>Zhang Xiangyu</investigator_full_name>
    <investigator_title>Director of Intensive care medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pulmonary Heart Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
